LRRK2 and Parkinson disease: This suggests limited utility of urine BMP levels as a biomarker of PD progression, and further work to examine how BMP levels relate to other measures of LRRK2 kinase activity in sporadic PD patients is needed to determine any potential as a stratification biomarker for this population.